Thursday, March 24, 2016

UPDATE 1-Gilead ordered to pay Merck $200 mln in hepatitis C drug patent dispute

SAN JOSE, Calif.,/NEW YORK, March 24 (Reuters) - A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a...

Read more

No comments:

Post a Comment